Acrylamide applied during pregnancy causes the neurotoxic effect by lowering bdnf levels in thefetal brain
dc.contributor.author | Erdemli, Mehmet Erman | |
dc.contributor.author | Aladag, M. Arif | |
dc.contributor.author | Altinoz, Eyup | |
dc.contributor.author | Demirtas, Sezin | |
dc.contributor.author | Turkoz, Yusuf | |
dc.contributor.author | Yigitcan, Birgul | |
dc.contributor.author | Bag, Harika Gozukara | |
dc.date.accessioned | 2019-07-04T11:27:03Z | |
dc.date.available | 2019-07-04T11:27:03Z | |
dc.date.issued | 2018 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Objectives: The aim of this study is to elucidate the possible mechanism of neurotoxic effect of acrylamide (AA) applied during pregnancy on fetal brain development and to show the effect of N-acetylcysteine (NAC) on AA toxicity. Materials and methods: Four groups were formed with 9 pregnant rats each as control (C), acrylamide (AA), N-acetylcysteine (NAC), acrylamide plus N-acetylcysteine (AA plus NAC) groups. Caesarian section was implemented on the 20th day of pregnancy. Malondialdehyde (MDA), reduced glutathione (GSH), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), catalase (CAT) and Brain-derived neurotrophic factor (BDNF) levels were analyzed and histopathologic examinations were performed in brain tissues of the fetuses. Results: Our data indicated that AA caused necrotic death and hemorrhagic damages in fetal brain tissue with decreasing BNDF levels and increasing oxidative stress. N-acetylcysteine prevented the toxic effects of its on fetal brain (p < 0.05). Conclusion: Our study indicated that acrylamide has toxic effects in the fetal brain and N-acetylcysteine prevents its toxic effect. | en_US |
dc.identifier.citation | Erdemli, ME . Aladag, MA. Altinoz, E. Demirtas, S. Turkoz, Y. Yigitcan, B . Bag, HG. (2018). Acrylamide applied during pregnancy causes the neurotoxic effect by lowering bdnf levels in thefetal brain. Cilt:67. 37-43 ss. | en_US |
dc.identifier.doi | 10.1016/j.ntt.2018.03.005 | en_US |
dc.identifier.endpage | 43 | en_US |
dc.identifier.startpage | 37 | en_US |
dc.identifier.uri | https://hdl.handle.net/11616/12340 | |
dc.identifier.volume | 67 | en_US |
dc.language.iso | en | en_US |
dc.publisher | Pergamon-elsevıer scıence ltd, the boulevard, langford lane, kıdlıngton, oxford ox5 1gb, england | en_US |
dc.relation.ispartof | Neurotoxıcology and teratology | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | N-acetylcysteıne | en_US |
dc.subject | neurotrophıc factor | en_US |
dc.subject | dıetary-tınake | en_US |
dc.subject | rat | en_US |
dc.subject | food | en_US |
dc.subject | supplementatıon | en_US |
dc.subject | neuroprotectıon | en_US |
dc.subject | neurogenesıshıpp | en_US |
dc.subject | ocampus | en_US |
dc.subject | carcınogen | en_US |
dc.title | Acrylamide applied during pregnancy causes the neurotoxic effect by lowering bdnf levels in thefetal brain | en_US |
dc.type | Article | en_US |